Dow Up 0.24% Nasdaq Down 0.18%

Curis, Inc. (CRIS)

-NasdaqGM
1.63 Down 0.04(2.10%) 10:17AM EDT - Nasdaq Real Time Price
Prev Close:1.67
Open:1.66
Bid:1.63 x 1000
Ask:1.64 x 2400
1y Target Est:5.17
Beta:0.96
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:1.61 - 1.66
52wk Range:1.60 - 4.74
Volume:358,359
Avg Vol (3m):1,045,730
Market Cap:140.61M
P/E (ttm):N/A
EPS (ttm):-0.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CRISDown 2.10%140.61M
EXELDown 1.03%793.66M
INFIDown 1.32%524.54M
PFEDown 0.21%182.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.70
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.18
Quarterly EPS Est (Sep-14) :-0.04
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback